local_pharmacy

Voxilaprevir (BCRP/ABCG2 Inhibitors / BCRP/ABCG2 Substrates / Cytochrome P-450 CYP1A2 Substrates / OATP1B1 transporter inhibitors / OATP1B1/SLCO1B1 Substrates / OATP1B3 transporter inhibitors / P-glycoprotein/ABCB1 Inhibitors / P-glycoprotein/ABCB1 Substrates)

Voxilaprevir

BCRP/ABCG2 Inhibitors / BCRP/ABCG2 Substrates / Cytochrome P-450 CYP1A2 Substrates / OATP1B1 transporter inhibitors / OATP1B1/SLCO1B1 Substrates / OATP1B3 transporter inhibitors / P-glycoprotein/ABCB1 Inhibitors / P-glycoprotein/ABCB1 Substrates
Name Voxilaprevir
Rumus
C40H52F4N6O9S
UNSURJUMLAHBOBOT
C40480.428
H5252.41288
F475.9936128
N684.0402
O9143.9946
S132.065
Total Bobot Molekul 868.9342928
Therapeutic Indc Vosevi (Voxilaprevir/[DB08934]/[DB11613]) is approved for use in patients with genotypes 1-6 who have been previously treated with an NS5A inhibito...
Categories BCRP/ABCG2 Inhibitors / BCRP/ABCG2 Substrates / Cytochrome P-450 CYP1A2 Substrates / OATP1B1 transporter inhibitors / OATP1B1/SLCO1B1 Substrates / OATP1B3 transporter inhibitors / P-glycoprotein/ABCB1 Inhibitors / P-glycoprotein/ABCB1 Substrates
Structure C40H52F4N6O9S.svg
BACK